Global Elastomeric Infusion Pumps Market Forecast
- Elastomeric infusion pumps market size poised to reach US$1,900 Mn by 2031, up from US$981 Mn estimated in 2024
- Global elastomeric infusion pumps market revenue likely to exhibit a remarkable CAGR of 9.9% during the period from 2024 to 2031
Elastomeric Infusion Pumps Market Insights
- The rise in chronic illnesses and home-based treatments drives market growth. Technological innovations and increasing chronic disease burden drive growth.
- Major growth barriers include regulatory compliance, competition, and limited reimbursement coverage.
- Key trends in the elastomeric infusion pumps market include sustainable practices, and continuous innovation.
- Regulatory scenario impacts market entry, reimbursement policies, and material compatibility.
- Continuous-rate elastomeric pumps dominate due to consistent drug delivery, portability, and cost-effectiveness.
- The elastomeric infusion pumps market is experiencing significant growth driven by increasing chronic diseases, aging population, and advancements in technology.
- The market is characterized by a steady growth trajectory, with a projected CAGR of around 9%.
- Key applications of elastomeric infusion pumps include pain management, chemotherapy, and other chronic conditions.
- Increasing prevalence of chronic diseases, aging population, and technological advancements will drive market expansion.
- Integration of smart features for remote monitoring and data management will mark a major highlight in the elastomeric infusion pumps industry.
A Look Back and a Look Forward - Comparative Analysis
The elastomeric infusion pumps market is projected to experience significant growth both before and after 2024. The market size is estimated to reach US$1.9 Bn in 2031, up from US$981 Mn attained in 2024. The market revenue is expected to exhibit a remarkable rate of expansion, with an estimated CAGR of 9.9% during the period from 2024 to 2031. Before 2023, the market had already shown positive growth. In 2019, the revenue from the global elastomeric infusion pumps market reached US$0.9 Bn. This growth was attributed to due to the rise in chronic illnesses and the popularity of home-based infusions for convenient treatment.
After 2024, the market is expected to continue its growth trajectory. The global elastomeric infusion pump market size is projected to be worth US$1.2 Bn in 2024 and is anticipated to reach US$2.6 Bn by 2034, with a CAGR of 7.9%. This growth is expected to be driven by their longer durations, improved accuracy, and lower infection risks. The market expansion is driven by portability, ease of use, and cost-effectiveness, making them a preferred choice for patients and healthcare providers.
How Does Regulatory Scenario Shape this Industry?
The regulatory scenario for the elastomeric infusion pumps market is an important factor shaping the industry. Regulatory approvals and support with funding are expected to boost the demand growth of healthcare and medical device industries, including elastomeric pump manufacturers. These manufacturers are gradually focusing on advancements in their existing products, innovating new products, and introducing digital platforms to increase elastomeric infusion pumps market penetration.
However, there are certain challenges and considerations in the regulatory landscape. Studies and literature have shown that the performance of elastomeric infusion pumps can vary depending on factors such as temperature and viscosity of the diluent or drug library. Additionally, there have been reports of errors associated with these pumps, including alarm errors, software problems, inadequate user interface design, and damaged components, which can impede demand growth.
As per the elastomeric infusion pumps overview, regulatory bodies in different regions have stringent requirements for medical devices, which can sometimes delay product launches. Furthermore, electronic infusion pumps offer higher precision and flexibility, posing competition to elastomeric pumps. The United States Food and Drug Administration (FDA) has a well-established regulatory framework for medical devices, including elastomeric pumps, which encourages manufacturers to bring new products to market quickly.
Key Growth Determinants
Increasing Prevalence of Chronic Diseases
One of the significant drivers for the elastomeric infusion pumps market growth is the increasing prevalence of chronic diseases. Chronic conditions such as cancer, diabetes, and cardiovascular diseases require long-term management and often involve regular administration of medications. Elastomeric infusion pumps are highly effective in delivering a controlled and continuous supply of medications over an extended period, making them an ideal choice for patients with chronic diseases. The rising burden of chronic diseases globally is driving the elastomeric infusion pumps market demand, as they provide convenience, reduce hospital visits, and improve patient compliance.
Growing Aging Population
The world's population is aging, and this demographic trend is another key driver for the elastomeric infusion pumps market revenue. As individuals age, the likelihood of developing chronic diseases increases. Elderly patients often require multiple medications and may have difficulty managing complex treatment regimens.
Elastomeric infusion pumps simplify the administration process by delivering medications continuously, eliminating the need for frequent injections or oral medication intake. With the aging population on the rise, the elastomeric infusion pumps market sales are expected to grow, as they offer a practical solution for managing medication delivery in older individuals.
Advancements in Infusion Pump Technology
As per the elastomeric infusion pumps market analysis, technological advancements in infusion pump technology are driving the industry growth. Manufacturers are continuously investing in research and development to improve the performance and functionality of elastomeric pumps. These advancements include features such as enhanced flow rate control, improved accuracy, and the integration of digital platforms for remote monitoring and data collection.
Additionally, the development of elastomeric pumps with smart features, such as wireless connectivity and compatibility with electronic health records, is further fueling the elastomeric infusion pumps market revenue. These technological advancements not only enhance the user experience but also ensure better patient outcomes, driving the adoption of elastomeric infusion pumps in healthcare settings.
Major Growth Barriers
Inaccurate Flow Rate and Lack of Alarms
One of the key restraints for the elastomeric infusion pumps market demand is the issue of inaccurate flow rate and the absence of alarms. Studies have shown that the flow rate accuracy of elastomeric pumps can vary, leading to potential under or over-delivery of medications. This can impact patient safety and treatment efficacy.
Additionally, the absence of alarms in elastomeric pumps makes it challenging to detect abnormal drug delivery or potential errors. These limitations can hinder the adoption of elastomeric infusion pumps, as healthcare providers may prefer alternative infusion methods that offer more precise control and monitoring of medication delivery.
Competition from Alternative Infusion Methods
The elastomeric infusion pumps market faces competition from alternative infusion methods, which can act as a growth restraint. Electronic infusion pumps, for example, offer advanced features such as programmable flow rates, dose calculations, and real-time monitoring. These electronic pumps provide healthcare providers with greater control and customization options for medication delivery.
While elastomeric pumps have advantages such as portability and ease of use, the availability of alternative infusion methods may impact elastomeric infusion pumps market expansion. Healthcare providers may opt for electronic pumps or other alternatives based on their specific requirements and preferences.
Elastomeric Infusion Pumps Market Trends and Opportunities
Technological Advancements, and Introduction of Disposable Pumps
One of the prominent elastomeric infusion pumps market trends is the continuous technological advancements and the introduction of disposable pumps. According to the search results, technological advancements and the introduction of disposable pumps are key trends in the market. The elastomeric infusion pumps market manufacturers are investing in research and development to improve the performance and functionality of elastomeric pumps. These advancements include features such as enhanced flow rate control, improved accuracy, and the integration of digital platforms for remote monitoring and data collection.
Additionally, the introduction of disposable pumps offers convenience and reduces the risk of contamination, making them a preferred choice for healthcare providers and patients. These trends not only enhance the user experience but also contribute to better patient outcomes, driving the growth of the elastomeric infusion pumps market.
Growing Focus on Home Healthcare Services
One of the elastomeric infusion pumps market opportunities lies in the growing focus on home healthcare services. The preference for comfort and cost-effectiveness has led to a rising trend towards home-based healthcare solutions. Elastomeric infusion pumps provide a practical solution for delivering medications in the home setting, allowing patients to receive necessary treatments in the comfort of their own homes.
This trend is driven by the increasing prevalence of ambulatory care centers and outpatient settings, where elastomeric pumps are utilized for efficient and controlled drug delivery during short-term treatments, surgeries, or diagnostic procedures. The opportunity for elastomeric infusion pumps lies in catering to the demand for more convenient and patient-centered care in the home healthcare setting. By addressing the needs of the growing home healthcare market, the elastomeric infusion pumps market can expand its reach and drive further growth.
Segments Covered in Elastomeric Infusion Pumps Market Report
Continuous Rate Elastomeric Pumps Dominate Market for Reliable Drug Delivery
Based on the elastomeric infusion pumps market research report, continuous-rate elastomeric pumps are the preferred choice in the elastomeric infusion pumps industry due to their consistent drug delivery. They are widely used in scenarios where a steady infusion rate is crucial, such as pain management or chemotherapy.
These pumps are simple, portable, and cost-effective, providing a hassle-free solution that enhances patient mobility and comfort. Advancements in technology have further improved continuous rate elastomeric pumps, offering adjustable flow rates and enhanced safety mechanisms for wider application in medical settings.
Flexibility and Personalization Drive Adoption of Variable Rate Elastomeric Pumps
According to the elastomeric infusion pumps market update, variable-rate elastomeric pumps are gaining traction in the market as they offer flexible drug delivery tailored to individual patient needs. They allow healthcare providers to adjust infusion rates based on changing therapeutic requirements, providing personalized treatment approaches. These pumps are particularly valuable in critical care or ambulatory settings where medication dosages need to be varied over time.
By accommodating fluctuations in patient condition, variable rate pumps ensure precise medication administration, minimizing the risk of under or overdosing. As demand for personalized medicine grows, these pumps are expected to witness continued adoption and technological enhancements, increasing the elastomeric infusion pumps market sales.
Regional Analysis
North America Dominates with Advanced Healthcare Infrastructure, and Disease Prevalence
As per elastomeric infusion pumps market outlook, North America holds a prominent position in the industry due to several key factors. The region's advanced healthcare infrastructure, substantial healthcare expenditure, and the presence of major market players contribute significantly to its dominance. The increasing prevalence of chronic diseases, such as cancer and diabetes, drives the elastomeric infusion pumps market demand, including elastomeric ones. Favorable reimbursement policies and growing patient awareness further augment elastomeric infusion pumps market revenue, making North America a leading regional market for elastomeric infusion pumps.
Europe's Growing Market Gains from Aging Population, and Healthcare Advancements
Europe plays a pivotal role in the elastomeric infusion pumps market expansion due to various factors. The region's rising geriatric population, high prevalence of chronic diseases, and government initiatives supporting healthcare contribute to market expansion. Advancements in healthcare technology and the increasing adoption of home healthcare services also drive the demand for elastomeric infusion pumps. Strategic initiatives by market players, such as product launches and collaborations, further boost elastomeric infusion pumps market growth in Europe.
Recent Industry Developments
May 2024
An Iranian company has developed elastomeric infusion pumps for ambulatory drug delivery. These pumps, also known as pain pumps, inject specific doses of medicine into an elastomer tank, reducing pain during post-surgery periods. They are designed for continuous drug delivery, on-demand delivery, or a combination of continuous and on-demand drug delivery. Elastomeric pumps offer a safe alternative to electronic pump systems and work without external energy sources. They are designed for single use and operate by the continuous contraction of an elastomeric balloon filled with drugs.
February 2024
Smiths Medical is recalling over 50,000 Model 4000 syringe pumps due to persistent software issues. The FDA states the recall is a correction, not a product removal. The alarm system, control screen, and pump mechanism may fail, causing delayed care delivery. There has been one reported injury and no deaths. The recall follows similar notices for Medfusion 3500 and 4000 infusion pumps.
Fairfield’s Competitive Landscape Analysis
The competitive landscape of the elastomeric infusion pumps market is moderately fragmented and competitive, with several key players striving for market dominance. According to the elastomeric infusion pumps market concentration, some major companies operating in this market include Baxter International, B. Braun Melsungen AG, Nipro Corporation, Leventon, S.A.U, and Avanos Medical, Inc.
These companies are focusing on new product launches, collaborations, and innovations to expand their elastomeric infusion pumps market share. Furthermore, the market is witnessing advancements in technology and the introduction of disposable pumps, which are key trends in the industry.
Key Market Companies
- Baxter International Inc.
- Braun Melsungen AG
- Nipro Corporation
- Leventon, S.A.U
- Avanos Medical, Inc.
- Insulet Corporation
- Medtronic
- CareFusion (acquired by BD)
- Nipro Corporation
- Braun Melsungen AG
- BD (Becton, Dickinson and Company)
- Nipro Corporation
Global Elastomeric Infusion Pumps Market is Segmented as-
By Product
- Continuous Rate Elastomeric Pumps
- Variable Rate Elastomeric Pumps
By Treatment
- Pain Management
- Antibiotic/Antiviral
- Chemotherapy
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Home Care Settings
- Clinics
- Others
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Turkey
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Egypt
- Nigeria
- Rest of the Middle East & Africa
1. Executive Summary
1.1. Global Elastomeric Infusion Pumps Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Elastomeric Infusion Pumps Market Outlook, 2019 - 2031
3.1. Global Elastomeric Infusion Pumps Market Outlook, by Product, Value (US$ Mn), 2019 - 2031
3.1.1. Key Highlights
3.1.1.1. Continuous Rate Elastomeric Pumps
3.1.1.2. Variable Rate Elastomeric Pumps
3.2. Global Elastomeric Infusion Pumps Market Outlook, by Treatment, Value (US$ Mn), 2019 - 2031
3.2.1. Key Highlights
3.2.1.1. Pain Management
3.2.1.2. Antibiotic/Antiviral
3.2.1.3. Chemotherapy
3.2.1.4. Others
3.3. Global Elastomeric Infusion Pumps Market Outlook, by End User, Value (US$ Mn), 2019 - 2031
3.3.1. Key Highlights
3.3.1.1. Hospitals
3.3.1.2. Ambulatory Surgical Centers
3.3.1.3. Home Care Settings
3.3.1.4. Clinics
3.3.1.5. Others
3.4. Global Elastomeric Infusion Pumps Market Outlook, by Region, Value (US$ Mn), 2019 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Elastomeric Infusion Pumps Market Outlook, 2019 - 2031
4.1. North America Elastomeric Infusion Pumps Market Outlook, by Product, Value (US$ Mn), 2019 - 2031
4.1.1. Key Highlights
4.1.1.1. Continuous Rate Elastomeric Pumps
4.1.1.2. Variable Rate Elastomeric Pumps
4.2. North America Elastomeric Infusion Pumps Market Outlook, by Treatment, Value (US$ Mn), 2019 - 2031
4.2.1. Key Highlights
4.2.1.1. Pain Management
4.2.1.2. Antibiotic/Antiviral
4.2.1.3. Chemotherapy
4.2.1.4. Others
4.3. North America Elastomeric Infusion Pumps Market Outlook, by End User, Value (US$ Mn), 2019 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Ambulatory Surgical Centers
4.3.1.3. Home Care Settings
4.3.1.4. Clinics
4.3.1.5. Others
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Elastomeric Infusion Pumps Market Outlook, by Country, Value (US$ Mn), 2019 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
4.4.1.2. U.S. Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
4.4.1.3. U.S. Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
4.4.1.4. Canada Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
4.4.1.5. Canada Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
4.4.1.6. Canada Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Elastomeric Infusion Pumps Market Outlook, 2019 - 2031
5.1. Europe Elastomeric Infusion Pumps Market Outlook, by Product, Value (US$ Mn), 2019 - 2031
5.1.1. Key Highlights
5.1.1.1. Continuous Rate Elastomeric Pumps
5.1.1.2. Variable Rate Elastomeric Pumps
5.2. Europe Elastomeric Infusion Pumps Market Outlook, by Treatment, Value (US$ Mn), 2019 - 2031
5.2.1. Key Highlights
5.2.1.1. Pain Management
5.2.1.2. Antibiotic/Antiviral
5.2.1.3. Chemotherapy
5.2.1.4. Others
5.3. Europe Elastomeric Infusion Pumps Market Outlook, by End User, Value (US$ Mn), 2019 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Ambulatory Surgical Centers
5.3.1.3. Home Care Settings
5.3.1.4. Clinics
5.3.1.5. Others
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Elastomeric Infusion Pumps Market Outlook, by Country, Value (US$ Mn), 2019 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
5.4.1.2. Germany Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
5.4.1.3. Germany Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
5.4.1.4. U.K. Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
5.4.1.5. U.K. Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
5.4.1.6. U.K. Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
5.4.1.7. France Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
5.4.1.8. France Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
5.4.1.9. France Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
5.4.1.10. Italy Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
5.4.1.11. Italy Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
5.4.1.12. Italy Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
5.4.1.13. Turkey Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
5.4.1.14. Turkey Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
5.4.1.15. Turkey Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
5.4.1.16. Russia Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
5.4.1.17. Russia Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
5.4.1.18. Russia Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
5.4.1.19. Rest of Europe Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
5.4.1.20. Rest of Europe Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
5.4.1.21. Rest of Europe Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Elastomeric Infusion Pumps Market Outlook, 2019 - 2031
6.1. Asia Pacific Elastomeric Infusion Pumps Market Outlook, by Product, Value (US$ Mn), 2019 - 2031
6.1.1. Key Highlights
6.1.1.1. Continuous Rate Elastomeric Pumps
6.1.1.2. Variable Rate Elastomeric Pumps
6.2. Asia Pacific Elastomeric Infusion Pumps Market Outlook, by Treatment, Value (US$ Mn), 2019 - 2031
6.2.1. Key Highlights
6.2.1.1. Pain Management
6.2.1.2. Antibiotic/Antiviral
6.2.1.3. Chemotherapy
6.2.1.4. Others
6.3. Asia Pacific Elastomeric Infusion Pumps Market Outlook, by End User, Value (US$ Mn), 2019 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Ambulatory Surgical Centers
6.3.1.3. Home Care Settings
6.3.1.4. Clinics
6.3.1.5. Others
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Elastomeric Infusion Pumps Market Outlook, by Country, Value (US$ Mn), 2019 - 2031
6.4.1. Key Highlights
6.4.1.1. China Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
6.4.1.2. China Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
6.4.1.3. China Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
6.4.1.4. Japan Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
6.4.1.5. Japan Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
6.4.1.6. Japan Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
6.4.1.7. South Korea Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
6.4.1.8. South Korea Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
6.4.1.9. South Korea Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
6.4.1.10. India Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
6.4.1.11. India Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
6.4.1.12. India Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
6.4.1.13. Southeast Asia Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
6.4.1.14. Southeast Asia Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
6.4.1.15. Southeast Asia Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
6.4.1.16. Rest of Asia Pacific Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
6.4.1.17. Rest of Asia Pacific Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
6.4.1.18. Rest of Asia Pacific Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Elastomeric Infusion Pumps Market Outlook, 2019 - 2031
7.1. Latin America Elastomeric Infusion Pumps Market Outlook, by Product, Value (US$ Mn), 2019 - 2031
7.1.1. Key Highlights
7.1.1.1. Continuous Rate Elastomeric Pumps
7.1.1.2. Variable Rate Elastomeric Pumps
7.2. Latin America Elastomeric Infusion Pumps Market Outlook, by Treatment, Value (US$ Mn), 2019 - 2031
7.2.1. Key Highlights
7.2.1.1. Pain Management
7.2.1.2. Antibiotic/Antiviral
7.2.1.3. Chemotherapy
7.2.1.4. Others
7.3. Latin America Elastomeric Infusion Pumps Market Outlook, by End User, Value (US$ Mn), 2019 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Ambulatory Surgical Centers
7.3.1.3. Home Care Settings
7.3.1.4. Clinics
7.3.1.5. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Elastomeric Infusion Pumps Market Outlook, by Country, Value (US$ Mn), 2019 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
7.4.1.2. Brazil Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
7.4.1.3. Brazil Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
7.4.1.4. Mexico Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
7.4.1.5. Mexico Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
7.4.1.6. Mexico Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
7.4.1.7. Argentina Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
7.4.1.8. Argentina Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
7.4.1.9. Argentina Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
7.4.1.10. Rest of Latin America Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
7.4.1.11. Rest of Latin America Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
7.4.1.12. Rest of Latin America Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Elastomeric Infusion Pumps Market Outlook, 2019 - 2031
8.1. Middle East & Africa Elastomeric Infusion Pumps Market Outlook, by Product, Value (US$ Mn), 2019 - 2031
8.1.1. Key Highlights
8.1.1.1. Continuous Rate Elastomeric Pumps
8.1.1.2. Variable Rate Elastomeric Pumps
8.2. Middle East & Africa Elastomeric Infusion Pumps Market Outlook, by Treatment, Value (US$ Mn), 2019 - 2031
8.2.1. Key Highlights
8.2.1.1. Pain Management
8.2.1.2. Antibiotic/Antiviral
8.2.1.3. Chemotherapy
8.2.1.4. Others
8.3. Middle East & Africa Elastomeric Infusion Pumps Market Outlook, by End User, Value (US$ Mn), 2019 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Ambulatory Surgical Centers
8.3.1.3. Home Care Settings
8.3.1.4. Clinics
8.3.1.5. Others
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Elastomeric Infusion Pumps Market Outlook, by Country, Value (US$ Mn), 2019 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
8.4.1.2. GCC Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
8.4.1.3. GCC Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
8.4.1.4. South Africa Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
8.4.1.5. South Africa Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
8.4.1.6. South Africa Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
8.4.1.7. Egypt Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
8.4.1.8. Egypt Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
8.4.1.9. Egypt Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
8.4.1.10. Nigeria Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
8.4.1.11. Nigeria Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
8.4.1.12. Nigeria Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
8.4.1.13. Rest of Middle East & Africa Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
8.4.1.14. Rest of Middle East & Africa Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
8.4.1.15. Rest of Middle East & Africa Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By End User vs By Application Heat map
9.2. Manufacturer vs by Treatment Heatmap
9.3. Company Market Share Analysis, 2022
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Baxter International, Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Fresenius Kabi AG
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. B. Braun Melsungen AG
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Ambu A/S
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Leventon, S.A.U.
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Nipro Corporation
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Terumo Corporation
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Avanos Medical, Inc.
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations
|
BASE YEAR |
HISTORICAL DATA |
FORECAST PERIOD |
UNITS |
|||
 |
2023 |
 |
2019 - 2023 |
 |
2024 - 2031 |
Value: US$ Million |
|
REPORT FEATURES |
DETAILS |
|
Product Coverage |
|
|
Treatment Coverage |
|
|
End User Coverage |
|
|
Geographical Coverage |
|
|
Leading Companies |
|
|
Report Highlights |
Key Market Indicators, Macro-micro economic impact analysis, Technological Roadmap, Key Trends, Driver, Restraints, and Future Opportunities & Revenue Pockets, Porter’s 5 Forces Analysis, Historical Trend (2019-2021), Market Estimates and Forecast, Market Dynamics, Industry Trends, Competition Landscape, Category, Region, Country-wise Trends & Analysis, COVID-19 Impact Analysis (Demand and Supply Chain) |
Quality assured
